Drops in pharmaceutical stock prices weighed down Dow and the S&P 500 on Friday, with Amgen down about 4.2 percent, Moderna off by 7.3 percent, Pfizer down 4 percent just to name a few – with the SPDR S&P Biotech ETF dropping more than 5 percent and posting its worst week since 2020 – a direct reaction to President-Elect Trump’s plan to nominate phone sex freak Robert F Kennedy Jr to lead the Department of Health and Human Services, CNBC reports on more winning.